NCT04337684进行中（未招募）不适用
Long Term Follow-Up and Collection of Historical Control Data on Menkes Disease Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Long Term Follow-Up on Survival
研究概览
简要总结
This study will collect long term follow-up data regarding overall survival and neurological parameters from patients previously identified and/or enrolled in Protocols 09-CH-0059 and 90-CH0149 and Historical Control data on Menkes disease patients.
详细描述
Primary Objective:
- To provide additional clinical and safety data on long term following administration of Copper Histidinate treatment in patients treated with Copper Histidinate under Protocols 09-CH-0059 and 90-CH0149 and untreated patients previously identified and/or enrolled in Protocol 09-CH-0059.
- To provide additional Historical Control data on Menkes disease patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The subject must have been previously identified and/or enrolled under Protocols 09-CH-0059 or 90-CH-0149; or An untreated Menkes disease patients for whom data collection is incomplete under Protocols 09-CH-0059 (Amendment M); or Other untreated Menkes disease patients.
- •Must sign and date an informed consent form by parent or legal guardian for this study prior to any assessment being done in this study. If the patient is > 18 years of age, the patient must sign the informed consent.
- •Male or female, aged 0 to < 65 years of age.
排除标准
- •- Unwillingness/unable to participate in the study.
研究组 & 干预措施
Treated with Copper Histidinate
干预措施: Long Term Follow-Up (Drug)
Historical Control
结局指标
主要结局
Long Term Follow-Up on Survival
时间窗: 12/01/2019 - 12/31/2022
The primary outcome measure will be overall survival.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy ProductHematological MalignancySolid Tumor MalignancyNCT05768269Century Therapeutics, Inc.375
已完成
不适用
Long-term Data Collection for Subjects in MDX-010 StudiesMetastatic MelanomaNCT00928031Bristol-Myers Squibb160
终止
不适用
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging AgentCoronary Artery DiseaseNCT00584714Point Biomedical300
已完成
不适用
Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012Carcinoma, Renal CellNCT01056263Pfizer52
已完成
不适用
Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell TransplantHematopoietic Stem Cell TransplantationNCT00674882St. Jude Children's Research Hospital637